Population-based Canadian hip fracture rates with international comparisons von Leslie, W. D, O'Donnell, S, Lagacé, C, Walsh, P, Bancej, C, Jean, S, Siminoski, K, Kaiser, S, Kendler, D. L, Jaglal, S

Volltext

Diagnosis and management of bone fragility in diabetes: an emerging challenge von Ferrari, S.L., Abrahamsen, B., Napoli, N., Akesson, K., Chandran, M., Eastell, R., El-Hajj Fuleihan, G., Josse, R., Kendler, D.L., Kraenzlin, M., Suzuki, A., Pierroz, D.D., Schwartz, A.V., Leslie, W.D.

Volltext

Vertebral Fractures: Clinical Importance and Management von Kendler, D.L., MD, Bauer, D.C., MD, Davison, K.S., PhD, Dian, L., MBBS, Hanley, D.A., MD, Harris, S.T., MD, McClung, M.R., MD, Miller, P.D., MD, Schousboe, J.T., MD, Yuen, C.K., MD, MBA, Lewiecki, E.M., MD

Volltext

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies von Kendler, D. L., Chines, A., Brandi, M. L., Papapoulos, S., Lewiecki, E. M., Reginster, J-Y., Muñoz Torres, M., Wang, A., Bone, H. G.

Volltext

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years von Ferrari, S., Adachi, J. D., Lippuner, K., Zapalowski, C., Miller, P. D., Reginster, J.-Y., Törring, O., Kendler, D. L., Daizadeh, N. S., Wang, A., O’Malley, C. D., Wagman, R. B., Libanati, C., Lewiecki, E. M.

Volltext

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate von Kendler, D. L., McClung, M. R., Freemantle, N., Lillestol, M., Moffett, A. H., Borenstein, J., Satram-Hoang, S., Yang, Y.-C., Kaur, P., Macarios, D., Siddhanti, S.

Volltext

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study von Silverman, S. L., Chines, A. A., Kendler, D. L., Kung, A. W. C., Teglbjærg, C. S., Felsenberg, D., Mairon, N., Constantine, G. D., Adachi, J. D.

Volltext

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis von Brown, J P, Kendler, D L, McClung, M R, Emkey, R D, Adachi, J D, Bolognese, M A, Li, Z, Balske, A, Lindsay, R

Volltext

Osteoporosis management in hematologic stem cell transplant recipients: Executive summary von Kendler, D.L., Body, J.J., Brandi, M.L., Broady, R., Cannata-Andia, J., Cannata-Ortiz, M.J., El Maghraoui, A., Guglielmi, G., Hadji, P., Pierroz, D.D., de Villiers, T.J., Ebeling, P.R., Rizzoli, R.

Volltext

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry von Lewiecki, E. M., Gordon, C. M., Baim, S., Binkley, N., Bilezikian, J. P., Kendler, D. L., Hans, D. B., Silverman, S., Bishop, N. J., Leonard, M. B., Bianchi, M.-L., Kalkwarf, H. J., Langman, C. B., Plotkin, H., Rauch, F., Zemel, B. S.

Volltext

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab von Kendler, D.L., Bone, H.G., Massari, F., Gielen, E., Palacios, S., Maddox, J., Yan, C., Yue, S., Dinavahi, R.V., Libanati, C., Grauer, A.

Volltext

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study von Papapoulos, S., Lippuner, K., Roux, C., Lin, C. J. F., Kendler, D. L., Lewiecki, E. M., Brandi, M. L., Czerwiński, E., Franek, E., Lakatos, P., Mautalen, C., Minisola, S., Reginster, J. Y., Jensen, S., Daizadeh, N. S., Wang, A., Gavin, M., Libanati, C., Wagman, R. B., Bone, H. G.

Volltext

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass von Kendler, D. L, Bessette, L, Hill, C. D, Gold, D. T, Horne, R, Varon, S. F, Borenstein, J, Wang, H, Man, H.-S, Wagman, R. B, Siddhanti, S, Macarios, D, Bone, H. G

Volltext

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspec... von Hiligsmann, M., Reginster, J.-Y., Tosteson, A.N.A., Bukata, S.V., Saag, K.G., Gold, D.T., Halbout, P., Jiwa, F., Lewiecki, E.M., Pinto, D., Adachi, J.D., Al-Daghri, N., Bruyère, O., Chandran, M., Cooper, C., Harvey, N.C., Einhorn, T.A., Kanis, J.A., Kendler, D.L., Messina, O.D., Rizzoli, R., Si, L., Silverman, S.

Volltext

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women von Freemantle, N., Satram-Hoang, S., Tang, E.-T., Kaur, P., Macarios, D., Siddhanti, S., Borenstein, J., Kendler, D. L.

Volltext

Special report on the official positions of the International Society for Clinical Densitometry von LEWIECKI, E. M, KENDLER, D. L, KIEBZAK, G. M, SCHMEER, P, PRINCE, R. L, FULEIHAN, G. El-Hajj, HANS, D

Volltext

Monitoring strontium ranelate therapy in patients with osteoporosis von Kendler, D. L, Adachi, J. D, Josse, R. G, Slosman, D. O

Volltext

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis von Adachi, Jonathan D, Bensen, William G, Brown, Jacques, Hanley, David, Hodsman, Anthony, Josse, Robert, Kendler, David L, Lentle, Brian, Olszynski, Wojciech, Ste.-Marie, Louis-George, Tenenhouse, Alan, Chines, Arkadi A, Jovaisas, Algis, Sturtridge, William C, Anastassiades, Tassos P, Hanly, John G, Pope, Janet E, Dias, Reginald, Horowitz, Zebulun D, Pack, Simon

Volltext

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate von RITTMASTER, R. S, BOLOGNESE, M, ETTINGER, M. P, HANLEY, D. A, HODSMAN, A. B, KENDLER, D. L, ROSEN, C. J

Volltext

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis von Kendler, D. L, Ringe, J. D, Ste-Marie, L. -G, Vrijens, B, Taylor, E. B, Delmas, P. D

Volltext